BACKGROUND: It remains unknown whether patients with severe decompensated class IV heart failure (HF) receiving intravenous inotropic treatment benefit from cardiac resynchronization therapy (CRT). METHODS: We identified patients who underwent urgent CRT implantation due to decompensated class IV HF necessitating intravenous inotropic therapy. RESULTS: Of 10 patients with chronic ischemic cardiomyopathy (median QRS duration of 170 ms), CRT implantation was associated with symptomatic improvement in 8 patients. The mortality rate was 50% during a median follow-up of 9.5 months, with a median CRT-to-death duration of 6 months. CONCLUSIONS: CRT was feasible among class IV patients receiving inotropic treatment and was associated with clinical improvement. Copyright 2006 S. Karger AG, Basel
BACKGROUND: It remains unknown whether patients with severe decompensated class IV heart failure (HF) receiving intravenous inotropic treatment benefit from cardiac resynchronization therapy (CRT). METHODS: We identified patients who underwent urgent CRT implantation due to decompensated class IV HF necessitating intravenous inotropic therapy. RESULTS: Of 10 patients with chronic ischemic cardiomyopathy (median QRS duration of 170 ms), CRT implantation was associated with symptomatic improvement in 8 patients. The mortality rate was 50% during a median follow-up of 9.5 months, with a median CRT-to-death duration of 6 months. CONCLUSIONS: CRT was feasible among class IV patients receiving inotropic treatment and was associated with clinical improvement. Copyright 2006 S. Karger AG, Basel
Authors: Aamir Jeewa; Alexander F Pitfield; James E Potts; Wendy Soulikias; Eustace S DeSouza; A J Hollinger; George G S Sandor; Jacques G LeBlanc; Andrew M Campbell; Shubhayan Sanatani Journal: Pediatr Cardiol Date: 2010-02 Impact factor: 1.655
Authors: Faisal Zaeem; Dalia Giedriemiene; Craig Coleman; Eric Crespo; Joseph Radojevic; Steven Zweibel; Jeffrey Kluger; Christopher A Clyne Journal: Cardiol Res Pract Date: 2012-07-30 Impact factor: 1.866